)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Beijing Wantai Biological Pharmacy Enterprise Co.
Beijing Wantai Biological Pharmacy Enterprise Co. (603392) investor relations material
Beijing Wantai Biological Pharmacy Enterprise Co. Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary26 Oct, 2026
Executive summary
Q3 revenue RMB 574.1m, down 12.33% YoY; attributable net loss RMB 102.5m and adjusted net loss RMB 117.2m.
9M revenue RMB 1.623bn, up 8.29% YoY; attributable net loss RMB 230.8m, versus net income of RMB 173.4m a year earlier.
Financial highlights
9M operating costs totaled RMB 1.821bn, including RMB 593.8m cost of sales, RMB 499.2m selling expense and RMB 409.0m R&D expense.
9M operating loss was RMB 228.2m and total loss before tax was RMB 236.5m; net loss was RMB 231.9m.
9M reported net loss attributable to shareholders was RMB 230.8m; excluding non-recurring items, the loss was RMB 286.1m.
9M other income was RMB 21.9m, investment income RMB 44.7m and fair-value gains RMB 13.5m.
Segment performance
Nine-valent HPV vaccine revenue increased in 9M, supporting higher overall gross profit and narrowing the year-on-year adjusted net loss, according to the stated explanation.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Beijing Wantai Biological Pharmacy Enterprise Co.
- Revenue up 24% YoY, net loss narrows, driven by HPV vaccine growth and global expansion.603392
Q2 2026 - HPV vaccine sales drove 30% revenue growth, with narrowed net loss and improved segment performance.603392Q1 2026
- Revenue dropped 18.99% and net loss reached RMB -398 million amid vaccine market headwinds.603392Q4 2025
- Net loss of RMB 173.4 million amid revenue decline, but international vaccine sales surged.603392Q3 2025
- Revenue fell 38%, net loss ¥144M; diagnostics profitable, vaccines loss, further losses expected.603392Q2 2025
- Revenue and profit fell sharply on HPV vaccine headwinds, but diagnostics saw robust growth.603392Q3 2024
- H1 2024 revenue and profit plunged due to weak HPV vaccine sales, but diagnostics stayed stable.603392Q2 2024
- Q1 revenue dropped 46.76% and net loss reached RMB -52.78 million amid vaccine market headwinds.603392Q1 2025
- Revenue and profit fell sharply on weak vaccine sales, but diagnostics and R&D remained strong.603392Q4 2024
Next Beijing Wantai Biological Pharmacy Enterprise Co. earnings date
Q4 20262 Apr, 2027
Beijing Wantai Biological Pharmacy Enterprise Co.
Next Beijing Wantai Biological Pharmacy Enterprise Co. earnings date
Q4 20262 Apr, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. specializes in the research, development, production, and distribution of biopharmaceutical products. The company focuses on diagnostic reagents, vaccines, and other biological products used in the prevention and detection of infectious diseases. Its offerings serve healthcare institutions, laboratories, and public health organizations, aiming to support disease prevention and health management. The company is headquartered in Beijing, China, and its shares are listed on the SSE.